Elite Pharmaceuticals, Inc. (Public, OTC:ELTP)

109 posts / 0 new
Letzter Beitrag
b00n
Bild des Benutzers b00n
Offline
Zuletzt online: 15.07.2016
Mitglied seit: 15.02.2010
Kommentare: 5'227
Elite Pharmaceuticals, Inc. (Public, OTC:ELTP)

Elite Pharmaceuticals Announces FDA Approval for Generic Phentermine HCL Tablets

02/04/2011 @ 9:30AM

0.0510

+0.0060 (13.33%)

# 52 week 0.04 - 0.12

# Open 0.05

# Vol / Avg. 11.19M/1.55M

# Mkt cap 5.00M

# Shares 97.95M (mal nicht so grosses Dilutionsrisiko)

--->SHARES OUTSTANDING 97.9M (wäre dann 10mio mktcap)

# Beta 2.35

# Inst. own 36%

# EPS $ -0.02

kaum einer hats gemerkt!? ich denke die sind äusserst unterbewertet.

Dies ist dann nicht ihr erstes produkt auf dem markt! Zahlen scheinen sich deutlich gebessert zu haben. Vermarkten nicht selber, produzieren und kassieren lizenzgebühren.

ich denk es wird schwierig nochmal unter 0.05 zuschlagen zu können, evtl. diesen montag noch.

0.04 hat sich als bottom gezeigt. hier könnten gute 100% drinneliegen.. also je nach vol und momentum werd ich da montag mitmischen.

http://www.elitepharma.com/

b00n
Bild des Benutzers b00n
Offline
Zuletzt online: 15.07.2016
Mitglied seit: 15.02.2010
Kommentare: 5'227
Elite Pharmaceuticals, Inc. (Public, OTC:ELTP)

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

b00n
Bild des Benutzers b00n
Offline
Zuletzt online: 15.07.2016
Mitglied seit: 15.02.2010
Kommentare: 5'227
Elite Pharmaceuticals, Inc. (Public, OTC:ELTP)

beachtet den vol spike am 10/11.1

da kamen "blos" partnering news; wär toll wenn das montag so weitergeht, jetzt erst recht nach approved news.

Elite Pharmaceuticals And Hi-Tech Pharmacal Sign A Development And Supply Agreement For A Generic Intermediate Of A Prescription ProductElite

http://www.thestreet.com/story/10968778/1/elite-pharmaceuticals-and-hi-t...

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

b00n
Bild des Benutzers b00n
Offline
Zuletzt online: 15.07.2016
Mitglied seit: 15.02.2010
Kommentare: 5'227
Elite Pharmaceuticals, Inc. (Public, OTC:ELTP)

Here's a list of the things they have going on right now. How can the price of this still be so low?

Products, patents, assets:

17 products

LODRANE 24 & 24D - currently selling and growing

Hi-Tech product (last press release)

Hydromorphone Hydrochloride (Dilaudid) transfer from Mikah Pharma in progress

Naltrexone Hydrochloride– Mikah Pharma-

Methadone- Lawsuit with Pharma Network delaying commercialization-sucks, we need this-

ELI 216 – time release Oxy- waiting for trials, partner

ELI 154- 1X day Oxy-

Eight (8) products pursuant to the Epic Strategic Alliance

Gastrointestinal Disorder generic from IntelliPharmaceutics- haven't heard anything about this in years so maybe it is no longer viable

So figure at least 16 products at varying stages.

Patents- 7- two of which are assigned to Celgene- http://www.celgene.com/

10 % of Novel – a company similar to Elite itself

Now, a question for the CC would be when do they expect to see any return from their 3.2 million dollar investment in Novel. Given that they have been in Novel, (initially at 49% )since 2006 it doesn't seem unreasonable to want to hear some discussion as to how soon something will be realized from the investment.

Here's a Novel product coming online this year: Perigo.

http://www.halflytely.com/

OK, it's colonoscopy prep, big deal you say, until you read there are 6 million done per year, certainly more if health care becomes universal.

These things add up and it's business that will be there year after year.

In addition Novel has filed 11 ANDA 's since it's inception along with 3 ANDA's it's purchased and it has identified 50 drug products to commercialize in the coming years.

That's Elite's 3.2 million dollar asset. Does it look like that will grow? I believe it will. How will they monetize it is the question.

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

b00n
Bild des Benutzers b00n
Offline
Zuletzt online: 15.07.2016
Mitglied seit: 15.02.2010
Kommentare: 5'227
Elite Pharmaceuticals, Inc. (Public, OTC:ELTP)

je weiter ich grab desto spannender find ich das teil lol.

gogo eure einschätzungen pls !

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

b00n
Bild des Benutzers b00n
Offline
Zuletzt online: 15.07.2016
Mitglied seit: 15.02.2010
Kommentare: 5'227
Elite Pharmaceuticals, Inc. (Public, OTC:ELTP)

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

b00n
Bild des Benutzers b00n
Offline
Zuletzt online: 15.07.2016
Mitglied seit: 15.02.2010
Kommentare: 5'227
Elite Pharmaceuticals, Inc. (Public, OTC:ELTP)

"Elite currently manufactures Lodrane 24(R) and Lodrane 24D(R) which are marketed by our partner, ECR Pharmaceuticals, for allergy treatment, and in addition to this phentermine product, we expect to launch two additional products this year that will be marketed by TAGI. Collectively, these products will allow the company to fully realize the implementation of the business plan that was put in place to turn the company into a profitable operational company," commented Jerry Treppel, Chairman and CEO.

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

Leonator
Bild des Benutzers Leonator
Offline
Zuletzt online: 21.11.2017
Mitglied seit: 29.07.2007
Kommentare: 552
Elite Pharmaceuticals, Inc. (Public, OTC:ELTP)

Danke für die Thread - Eröffnung Biggrin

Hab gerade eine kleine Posi geladen EP 0.0521

--------------------------------------------------------------------


http://www.biotechinvestorsnetwork.com/#!top-gainers/c7py

b00n
Bild des Benutzers b00n
Offline
Zuletzt online: 15.07.2016
Mitglied seit: 15.02.2010
Kommentare: 5'227
Elite Pharmaceuticals, Inc. (Public, OTC:ELTP)

02/08/2011 @ 8:00AM

Elite Pharmaceuticals to Present at the 13th Annual BIO CEO & Investor Conference on February 14, 2011

A live webcast of Elite's presentation will be accessible on the company's website, www.elitepharma.com, and an archived recording will be available on the website through March 1, 2011.

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

b00n
Bild des Benutzers b00n
Offline
Zuletzt online: 15.07.2016
Mitglied seit: 15.02.2010
Kommentare: 5'227
Elite Pharmaceuticals, Inc. (Public, OTC:ELTP)

Elite Pharmaceuticals, Inc. to Discuss Third Quarter Results of Operations on Monday, February 14, 2011

Elite Pharma (OTCBB:ELTP)

Intraday Stock Chart

Today : Thursday 10 February 2011

Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral sustained and controlled release product formulations, announced today the Company will host a conference call to discuss the results of operations and provide an update on recent business developments on Monday, February 14, 2011 at 10:00 AM EST. Company executives will also conduct a question and answer session following their remarks.

To access the conference call:

Domestic callers: (800) 346-7359

International callers: (973) 528-0008

Conference Entry Code: 98840

A digital telephone replay will be available approximately one hour after the conclusion of the call for two weeks until February 28, 2011 by dialing:

Domestic callers: (800) 332-6854

International callers: (973) 528-0005

Conference entry code: 98840

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

b00n
Bild des Benutzers b00n
Offline
Zuletzt online: 15.07.2016
Mitglied seit: 15.02.2010
Kommentare: 5'227
Elite Pharmaceuticals, Inc. (Public, OTC:ELTP)

Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal 2011

Elite Pharma (OTCBB:ELTP)

Intraday Stock Chart

Today : Monday 14 February 2011

Click Here for more Elite Pharma Charts.

Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral controlled release product formulations, announced results for the fiscal third quarter ended December 31, 2011.

For the third quarter, consolidated revenues were $1.2 million, an increase of 34% compared with last year's third quarter, with substantially all revenues being derived from the manufacture, sale and lab services related to the Lodrane family of products.

Profits from operations were $72,931 for the third quarter, as compared to last year's third quarter operating losses of $509,893. This marks the first quarter in which the company has achieved an operating profit and is indicative of results achieved pursuant to the continuing efforts by management to increase manufacturing efficiency and reduce operating costs.

GAAP net income, including non-cash revenues and expenses relating to the accounting treatment of preferred share derivatives and the fair value of warrant derivatives, was $5.9 million. Basic net income was $0.06 per share and fully diluted net income was $0.02 per share.

For the first nine months of fiscal 2011, cash flow from operations was a positive $318,457, compared to a negative operating cash flow of ($1.1 million) for the same period last year. Approximately $400,000 of cash has been invested in the purchases, previously announced, of three approved ANDA's, and in the continued expansion and improvement of Elite's manufacturing facilities. Total net cash flow for the first three quarters, inclusive of cash from operations and cash used in investing and financing activities was a negative $162,993. Our cash balance as of December 31, 2010 was $415,194.

The company is currently in discussions to license its once daily oxycodone product, ELI-154, to a European marketing partner and is progressing towards scale-up in the development of its abuse-resistant formulation of oxycodone, ELI-216.

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

Leonator
Bild des Benutzers Leonator
Offline
Zuletzt online: 21.11.2017
Mitglied seit: 29.07.2007
Kommentare: 552
Elite Pharmaceuticals, Inc. (Public, OTC:ELTP)

Wieder mal Panikverkäufe kurz vor Börsenschluss :roll:

--------------------------------------------------------------------


http://www.biotechinvestorsnetwork.com/#!top-gainers/c7py

WARSICS
Bild des Benutzers WARSICS
Offline
Zuletzt online: 27.08.2013
Mitglied seit: 23.12.2010
Kommentare: 512
Elite Pharmaceuticals, Inc. (Public, OTC:ELTP)

Leonator wrote:

Wieder mal Panikverkäufe kurz vor Börsenschluss :roll:

.... war ich dabei. allerdings nicht panisch, sondern gediegen meine teile wieder abgeben. ziel erreicht = out.

Handelnder Holländer

b00n
Bild des Benutzers b00n
Offline
Zuletzt online: 15.07.2016
Mitglied seit: 15.02.2010
Kommentare: 5'227
Re: Elite Pharmaceuticals, Inc. (Public, OTC:ELTP)

b00n wrote:

Elite Pharmaceuticals Announces FDA Approval for Generic Phentermine HCL Tablets

02/04/2011 @ 9:30AM

0.0510

+0.0060 (13.33%)

# 52 week 0.04 - 0.12

# Open 0.05

# Vol / Avg. 11.19M/1.55M

# Mkt cap 5.00M

# Shares 97.95M (mal nicht so grosses Dilutionsrisiko)

--->SHARES OUTSTANDING 97.9M (wäre dann 10mio mktcap)

# Beta 2.35

# Inst. own 36%

# EPS $ -0.02

kaum einer hats gemerkt!? ich denke die sind äusserst unterbewertet.

Dies ist dann nicht ihr erstes produkt auf dem markt! Zahlen scheinen sich deutlich gebessert zu haben. Vermarkten nicht selber, produzieren und kassieren lizenzgebühren.

ich denk es wird schwierig nochmal unter 0.05 zuschlagen zu können, evtl. diesen montag noch.

0.04 hat sich als bottom gezeigt. hier könnten gute 100% drinneliegen.. also je nach vol und momentum werd ich da montag mitmischen.

http://www.elitepharma.com/

vol geht zurück..wird wohl wieder kommen..könnt noch etwas fallen.. aber sieht grundsätzlich gut aus oder!?

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

b00n
Bild des Benutzers b00n
Offline
Zuletzt online: 15.07.2016
Mitglied seit: 15.02.2010
Kommentare: 5'227
Elite Pharmaceuticals, Inc. (Public, OTC:ELTP)

Date : 03/04/2011 @ 8:15AM

Source : GlobeNewswire Inc.

Stock : Elite Pharmaceuticals, Inc. (ELTP)

Quote : 0.064 0.0 (0.00%) @ 7:50AM

FDA Action Affects Products Manufactured by Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. (OTCBB:ELTP) advises that the US Food and Drug Administration (FDA) announced that it intends to remove approximately 500 cough/cold and allergy related products from the U.S. market. Elite currently manufactures two of the drugs impacted by the FDA's action which are marketed by ECR Pharmaceuticals, a wholly owned subsidiary of Hi-Tech Pharmacal, Co., Inc. The affected products are:

Product Active Ingredient, Strength

Lodrane® 24 capsules brompheniramine maleate, 12mg

Lodrane® 24D capsules brompheniramine maleate, 12mg/pseudoephedrine HCl, 90mg

According to the FDA press release, manufacturers must stop manufacturing the affected products within 90 days after March 3, 2011 and must stop shipping these products within 180 days after March 3, 2011.

In addition to receiving revenues for the manufacture and contract laboratory services of these products, Elite receives a royalty on in-market sales from ECR Pharmaceuticals. Revenues generated from these products totaled $3.02 million for the 9 months ended December 31, 2010, representing substantially all of Elite's revenues for the period. The Company's inability to manufacture these drugs could have an adverse effect on its revenues.

As disclosed by Hi-Tech Pharmacal, ECR Pharmaceutical initiated in 2010 a formal approval process with the FDA regarding Lodrane® 24 and Lodrane® 24D and ECR will continue to actively pursue approval for both products.

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

b00n
Bild des Benutzers b00n
Offline
Zuletzt online: 15.07.2016
Mitglied seit: 15.02.2010
Kommentare: 5'227
Elite Pharmaceuticals, Inc. (Public, OTC:ELTP)

b00n wrote:

Date : 03/04/2011 @ 8:15AM

Source : GlobeNewswire Inc.

Stock : Elite Pharmaceuticals, Inc. (ELTP)

Quote : 0.064 0.0 (0.00%) @ 7:50AM

FDA Action Affects Products Manufactured by Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. (OTCBB:ELTP) advises that the US Food and Drug Administration (FDA) announced that it intends to remove approximately 500 cough/cold and allergy related products from the U.S. market. Elite currently manufactures two of the drugs impacted by the FDA's action which are marketed by ECR Pharmaceuticals, a wholly owned subsidiary of Hi-Tech Pharmacal, Co., Inc. The affected products are:

Product Active Ingredient, Strength

Lodrane® 24 capsules brompheniramine maleate, 12mg

Lodrane® 24D capsules brompheniramine maleate, 12mg/pseudoephedrine HCl, 90mg

According to the FDA press release, manufacturers must stop manufacturing the affected products within 90 days after March 3, 2011 and must stop shipping these products within 180 days after March 3, 2011.

In addition to receiving revenues for the manufacture and contract laboratory services of these products, Elite receives a royalty on in-market sales from ECR Pharmaceuticals. Revenues generated from these products totaled $3.02 million for the 9 months ended December 31, 2010, representing substantially all of Elite's revenues for the period. The Company's inability to manufacture these drugs could have an adverse effect on its revenues.

As disclosed by Hi-Tech Pharmacal, ECR Pharmaceutical initiated in 2010 a formal approval process with the FDA regarding Lodrane® 24 and Lodrane® 24D and ECR will continue to actively pursue approval for both products.

hat sich von obigem rücksetzer nun bestens erholt, und sieht nach kleinem break out aus

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

Leonator
Bild des Benutzers Leonator
Offline
Zuletzt online: 21.11.2017
Mitglied seit: 29.07.2007
Kommentare: 552
Elite Pharmaceuticals, Inc. (Public, OTC:ELTP)

Out 0.073 $

--------------------------------------------------------------------


http://www.biotechinvestorsnetwork.com/#!top-gainers/c7py

sharewatch
Bild des Benutzers sharewatch
Offline
Zuletzt online: 23.07.2015
Mitglied seit: 03.04.2010
Kommentare: 865
Elite Pharmaceuticals, Inc. (Public, OTC:ELTP)

Leonator wrote:

Out 0.073 $

Gratuliere Leonator :!:

Leonator
Bild des Benutzers Leonator
Offline
Zuletzt online: 21.11.2017
Mitglied seit: 29.07.2007
Kommentare: 552
Elite Pharmaceuticals, Inc. (Public, OTC:ELTP)

Danke sharewatch Biggrin

Jup...fast auf Tageshoch verkauft Wink

--------------------------------------------------------------------


http://www.biotechinvestorsnetwork.com/#!top-gainers/c7py

b00n
Bild des Benutzers b00n
Offline
Zuletzt online: 15.07.2016
Mitglied seit: 15.02.2010
Kommentare: 5'227
Elite Pharmaceuticals, Inc. (Public, OTC:ELTP)

Leonator wrote:

Out 0.073 $

joa gz GZ!

aber der chart lässt fantasie offen. vlt. nochma n rücksetzer gegn 0.06.. aber dann gehts los.

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

b00n
Bild des Benutzers b00n
Offline
Zuletzt online: 15.07.2016
Mitglied seit: 15.02.2010
Kommentare: 5'227
Elite Pharmaceuticals, Inc. (Public, OTC:ELTP)

b00n wrote:

Leonator wrote:
Out 0.073 $

joa gz GZ!

aber der chart lässt fantasie offen. vlt. nochma n rücksetzer gegn 0.06.. aber dann gehts los.

elitemässig top 8)

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

b00n
Bild des Benutzers b00n
Offline
Zuletzt online: 15.07.2016
Mitglied seit: 15.02.2010
Kommentare: 5'227
Elite Pharmaceuticals, Inc. (Public, OTC:ELTP)

scheint mir ausm seitwärtstrend raus zu wollen.

uptrend coming? Smile

gehe davon aus dass 0.06 halten sollte ab 0.068 wirds spannend

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

Leonator
Bild des Benutzers Leonator
Offline
Zuletzt online: 21.11.2017
Mitglied seit: 29.07.2007
Kommentare: 552
Elite Pharmaceuticals, Inc. (Public, OTC:ELTP)

Heute schnell auf die 0,094 $ hochgeschossen :shock:

--------------------------------------------------------------------


http://www.biotechinvestorsnetwork.com/#!top-gainers/c7py

b00n
Bild des Benutzers b00n
Offline
Zuletzt online: 15.07.2016
Mitglied seit: 15.02.2010
Kommentare: 5'227
Elite Pharmaceuticals, Inc. (Public, OTC:ELTP)

Elite Pharmaceuticals, Inc. Announces Third Closing of Strategic Alliance Agreement With Epic Pharma

Today : Wednesday 6 April 2011

Elite Pharmaceuticals, Inc. ("Elite") (OTCBB:ELTP) announced that on March 31, 2011 the company completed the third closing of the Strategic Alliance Agreement (the "Alliance") with Epic Pharma, LLC and Epic Investments, LLC, a wholly-owned subsidiary of Epic Pharma, LLC (collectively "Epic") pursuant to the terms in the Alliance entered into on March 18, 2009 and previously disclosed.

Pursuant to the Alliance, Epic agreed to invest $3.75 million in Elite through the purchase of Elite's Series E Preferred Stock and common stock warrants. In the March 31, 2011 closing, Epic made the third $1.0 million payment of this total amount, acquired 1,000 shares of Series E Preferred Stock and received a warrant registered to purchase up to forty million (40,000,000) shares of Common Stock at an exercise price of Six and 25/100 Cents ($0.0625) per share.

Under the Alliance (i) at least eight generic drug products will be developed by Epic at Elite's facility with the intent of filing abbreviated new drug applications for obtaining United States Food and Drug Administration ("FDA") approval of such generic drugs, (ii) Elite will be entitled to 15% of the profits generated from the sales of such additional generic drug products upon approval by the FDA, and (iii) Epic and Elite will share with each other certain resources, technology and know-how in the development of drug products, which Elite believes will benefit the continued development of its current drug products. Epic will also be entitled to receive additional shares of Elite's Common Stock and warrants to purchase shares of Elite's Common Stock upon achievement of certain milestones relating to the eight additional generic drug products being developed together. The first of these eight products has been filed with the FDA.

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

b00n
Bild des Benutzers b00n
Offline
Zuletzt online: 15.07.2016
Mitglied seit: 15.02.2010
Kommentare: 5'227
Elite Pharmaceuticals, Inc. (Public, OTC:ELTP)

Elite Pharmaceuticals Announces First Shipment of Generic Phentermine HCl Tablets

Elite Pharma (OTCBB:ELTP)

Intraday Stock Chart

Today : Thursday 7 April 2011

Click Here for more Elite Pharma Charts.

Elite Pharmaceuticals, Inc. ("Elite") (OTCBB:ELTP) announced today that the initial shipment of phentermine HCl 37.5 mg tablets, the generic version of Adipex-P® 37.5 mg tablets, was made, triggering a milestone payment under the License, Manufacturing and Supply Agreement with Precision Dose and its wholly owned subsidiary TAGI Pharma, Inc. TAGI Pharma will distribute the product as part of a multi-product distribution agreement.

Phentermine HCl is a member of the amphetamine and phenethylamine class. It is an appetite suppressant used to help reduce weight in obese patients when used short-term and combined with exercise, diet, and behavioral modification.

For the most recent twelve months ending December 2010, Adipex-P® and its generics had total U.S. sales of approximately $40 million according to IMS Health Data.

About TAGI Pharma, Inc.

TAGI Pharma was launched by Precision Dose in 2010 as a specialty pharmaceutical company focused on the Retail Market Segment. A key component of TAGI Pharma's strategy is the leveraging of its sales and distribution core competencies with the formation of strategic partnerships that have product development and manufacturing capabilities such as Elite. The phentermine HCl 37.5 mg product represents the first of these initiatives, and we expect an additional six product launches in the next six months. As the company sources products through development, acquisition and licensing opportunities, key areas of focus will be in the tablet, capsule and injectable dosage formats, with an emphasis on controlled substances, where there are additional barriers to entry. TAGI Pharma is located in South Beloit, Illinois, and additional information can be obtained from its website www.tagipharma.com.

0.093 0.0185 (24.83%)

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

b00n
Bild des Benutzers b00n
Offline
Zuletzt online: 15.07.2016
Mitglied seit: 15.02.2010
Kommentare: 5'227
Elite Pharmaceuticals, Inc. (Public, OTC:ELTP)

b00n wrote:

scheint mir ausm seitwärtstrend raus zu wollen.

uptrend coming? Smile

gehe davon aus dass 0.06 halten sollte ab 0.068 wirds spannend

schaut doch gut aus..

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

Leonator
Bild des Benutzers Leonator
Offline
Zuletzt online: 21.11.2017
Mitglied seit: 29.07.2007
Kommentare: 552
Elite Pharmaceuticals, Inc. (Public, OTC:ELTP)

Glückwunsch an alle die noch Shares halten :shock:

Bin leider zu früh raus... :cry:

--------------------------------------------------------------------


http://www.biotechinvestorsnetwork.com/#!top-gainers/c7py

b00n
Bild des Benutzers b00n
Offline
Zuletzt online: 15.07.2016
Mitglied seit: 15.02.2010
Kommentare: 5'227
Elite Pharmaceuticals, Inc. (Public, OTC:ELTP)

danke leo...

halte immer noch Smile grad ü 100%..

denke da geht mittlfristig noch einiges

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

WARSICS
Bild des Benutzers WARSICS
Offline
Zuletzt online: 27.08.2013
Mitglied seit: 23.12.2010
Kommentare: 512
Elite Pharmaceuticals, Inc. (Public, OTC:ELTP)

ich daytrade den seit 15:30 auf dem minuten und sogar sekundenchart. is ganz spannend!

edit: hat sich gelohnt Blum 3 (16:30), bin fertig mit dem titel.

Handelnder Holländer

b00n
Bild des Benutzers b00n
Offline
Zuletzt online: 15.07.2016
Mitglied seit: 15.02.2010
Kommentare: 5'227
Elite Pharmaceuticals, Inc. (Public, OTC:ELTP)

jaaaaa 8) lach

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

b00n
Bild des Benutzers b00n
Offline
Zuletzt online: 15.07.2016
Mitglied seit: 15.02.2010
Kommentare: 5'227
Elite Pharmaceuticals, Inc. (Public, OTC:ELTP)

warsics, haste noch welche liegen oder ausgetradet gestern? läuft prächtig weiter..

----gesperrt wegen gutmenschentum, wünsche an der stelle allen alles gute, wie immer. http://investorshub.advfn.com/boards/profilea.aspx?user=193864

Seiten